中国组织工程研究 ›› 2024, Vol. 28 ›› Issue (1): 56-61.doi: 10.12307/2024.103

• 牙髓及牙周膜干细胞 Dental pulp and periodontal ligament stem cells • 上一篇    下一篇

重组人生长激素促进人牙髓干细胞的成骨分化

孙  菁1,廖  健1,孙江龄2,程  萍2,冯红超1,2   

  1. 1贵州医科大学口腔医学院,贵州省贵阳市   550004;2贵阳市口腔医院,贵州省贵阳市   550002
  • 收稿日期:2023-01-30 接受日期:2023-03-04 出版日期:2024-01-08 发布日期:2023-06-28
  • 通讯作者: 冯红超,博士,教授,主任医师,贵州医科大学口腔医学院,贵州省贵阳市 550004;贵阳市口腔医院,贵州省贵阳市 550002
  • 作者简介:孙菁,女,1993年生,贵州省贵阳市人,汉族,贵州医科大学在读硕士,主要从事干细胞及骨组织工程相关方面的研究。
  • 基金资助:
    贵州省卫生健康委科学技术基金项目(gzwkj2022-431),项目负责人:冯红超

Recombinant human growth hormone promotes osteogenic differentiation of human dental pulp stem cells

Sun Jing1, Liao Jian1, Sun Jiangling2, Cheng Ping2, Feng Hongchao1, 2   

  1. 1School of Stomatology of Guizhou Medical University, Guiyang 550004, Guizhou Province, China; 2Guiyang Stomatology Hospital, Guiyang 550002, Guizhou Province, China
  • Received:2023-01-30 Accepted:2023-03-04 Online:2024-01-08 Published:2023-06-28
  • Contact: Feng Hongchao, MD, Professor, Chief physician, School of Stomatology of Guizhou Medical University, Guiyang 550004, Guizhou Province, China; Guiyang Stomatology Hospital, Guiyang 550002, Guizhou Province, China
  • About author:Sun Jing, Master candidate, School of Stomatology of Guizhou Medical University, Guiyang 550004, Guizhou Province, China
  • Supported by:
    Science and Technology Fund Project of Guizhou Provincial Health Commission, No. gzwkj2022-431 (to FHC)

摘要:


文题释义:

人生长激素:是垂体分泌的一种肽类激素,以往研究表明生长激素对人体骨代谢有非常重要的作用,它可通过调节成骨细胞表面受体的表达来影响成骨细胞的成骨和破骨功能。
基因重组人生长激素:是利用基因重组表达技术,研制出氨基酸序列及组成与人生长激素完全相同的生长激素,其与人体生长激素具有相同效价的作用。

牙髓干细胞:是外胚层来源的间充质干细胞,具有较高的自我更新能力、体外增殖能力、免疫调节能力,它们可在不同因子诱导下发挥多向分化潜能。


背景:既往研究表明人牙髓干细胞具有良好的成骨分化潜能,是骨组织工程中潜在的种子细胞,目前重组人生长激素对人牙髓干细胞的增殖及成骨分化的作用尚不明确。
目的:探究重组人生长激素对人牙髓干细胞增殖及成骨分化的影响。
方法:采用组织块培养法分离培养人牙髓干细胞,根据药物浓度梯度筛选后,选取10,100,250,500,1 000 μg/L重组人生长激素干预为实验组,正常培养基培养为对照组。在干预后第1,3,5,7天采用CCK-8法检测人牙髓干细胞的增殖情况。选取含10,100,250,500,1 000 μg/L重组人生长激素的成骨诱导液干预人牙髓干细胞,在诱导第7天,采用碱性磷酸酶染色及其半定量分析法检测碱性磷酸酶活性,采用荧光定量RT-qPCR检测成骨相关基因Ⅰ型胶原蛋白、骨钙素、Runt相关转录因子2的mRNA表达,在诱导第14天,采用茜素红染色观察成骨矿化情况。

结果与结论:①CCK-8检测结果显示,从干预第3天开始,100,250,500,1 000 μg/L重组人生长激素均能促进人牙髓干细胞增殖,与对照组相比差异有显著性意义(P < 0.01);②与对照组比较,100,250,500 μg/L重组人生长激素组人牙髓干细胞的碱性磷酸酶活性显著升高(P < 0.01);100,250 μg/L重组人生长激素组人牙髓干细胞的茜素红染色矿化结节数显著增多(P < 0.01);250 μg/L重组人生长激素组Ⅰ型胶原蛋白、骨钙素的mRNA表达量升高(P < 0.05,P < 0.01),100,250 μg/L重组人生长激素组Runt相关转录因子2的mRNA表达量升高(P < 0.01);③上述结果表明,250 μg/L重组人生长激素更适合促进人牙髓干细胞增殖和成骨分化。

https://orcid.org/0000-0003-0611-9005 (孙菁) 

中国组织工程研究杂志出版内容重点:干细胞;骨髓干细胞;造血干细胞;脂肪干细胞;肿瘤干细胞;胚胎干细胞;脐带脐血干细胞;干细胞诱导;干细胞分化;组织工程

关键词: 间充质干细胞, 人牙髓干细胞, 生长激素, 重组人生长激素, 细胞增殖, 成骨, 分化

Abstract: BACKGROUND: Previous studies have shown that human dental pulp stem cells have good osteogenic differentiation potential and are potential seed cells in bone tissue engineering, and the effect of recombinant human growth hormone on the proliferative osteogenic differentiation of human dental pulp stem cells is still unclear.
OBJECTIVE: To explore the effect of recombinant human growth hormone on the proliferation and osteogenic differentiation of human dental pulp stem cells.
METHODS: Human dental pulp stem cells were isolated and cultured by tissue block culture method. After screening according to the drug concentration gradient, recombinant human growth hormone containing 10, 100, 250, 500, 1 000 μg/L was selected as the experimental group, and 0 μg/L without recombinant human growth hormone was selected as the control group. CCK-8 detection reagents were used on days 1, 3, 5, and 7 after the drug intervention to detect the proliferation of human dental pulp stem cells. Different concentrations (10, 100, 250, 500, and 1 000 μg/L) of recombinant human growth hormone were added to the osteogenesis induction solution to intervene in human dental pulp stem cells. Alkaline phosphatase activity was detected by alkaline phosphatase staining and semi-quantitative analysis on day 7 of mineralization induction. The mRNA expression levels of osteogenic gene type I collagen, osteocalcin and Runt-related transcription factor 2 were detected by fluorescence quantitative RT-qPCR. Alizarin red staining was performed on day 14 of mineralization induction to detect osteogenic mineralized nodules.  
RESULTS AND CONCLUSION: (1) CCK-8 assay results showed that from the third day of intervention, the 100, 250, 500, 1 000 μg/L recombinant human growth hormone group could promote the proliferation of human dental pulp stem cells compared with the control group (P < 0.01). (2) The alkaline phosphatase activity of human dental pulp stem cells in the 100, 250, and 500 μg/L recombinant human growth hormone group was significantly increased compared with the control group (P < 0.01). The number of alizarin-stained mineralized nodules in human dental pulp stem cells in the 100, 250 μg/L recombinant human growth hormone group was significantly increased compared with the control group (P < 0.01). Compared with the control group, the mRNA expression of type I collagen and osteocalcin increased in the 250 μg/L recombinant human growth hormone group (P < 0.05, P < 0.01). mRNA expression of Runt-associated transcription factor 2 increased in the 100 and 250 μg/L recombinant human growth hormone groups (P < 0.01). (3) According to the above results, recombinant human growth hormone at a concentration of 250 μg/L is a more suitable concentration to promote the proliferation and osteogenic differentiation of human dental pulp stem cells.

Key words: mesenchymal stem cell, human dental pulp stem cell, growth hormone, recombinant human growth hormone, cell proliferation, osteogenesis, differentiation

中图分类号: